Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
This study has been completed.
Massachusetts General Hospital
Information provided by (Responsible Party):
Edwin Choy, MD, Massachusetts General Hospital
First received: April 18, 2012
Last updated: March 8, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||November 2014|
|Primary Completion Date:||January 2014 (Final data collection date for primary outcome measure)|
Choy E, Butrynski JE, Harmon DC, Morgan JA, George S, Wagner AJ, D'Adamo D, Cote GM, Flamand Y, Benes CH, Haber DA, Baselga JM, Demetri GD. Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy. BMC Cancer. 2014 Nov 5;14:813. doi: 10.1186/1471-2407-14-813.